Clinical implications of ctDNA for EGFR-TKIs as first-line treatment in NSCLC
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00432-022-03952-z.pdf
Reference23 articles.
1. Abbosh C et al (2017) Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature 545(7655):446–451
2. Anagnostou V et al (2019) Dynamics of tumor and immune responses during immune checkpoint blockade in non-small cell lung cancer. Cancer Res 79(6):1214–1225
3. Chen G et al (2021) Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer. J Hematol Oncol 14(1):80
4. Cheng ML et al (2021) Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions. CA Cancer J Clin 71(2):176–190
5. Esagian SM et al (2020) Comparison of liquid-based to tissue-based biopsy analysis by targeted next generation sequencing in advanced non-small cell lung cancer: a comprehensive systematic review. J Cancer Res Clin Oncol 146(8):2051–2066
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Concomitant genomic features stratify prognosis to patients with advanced EGFR mutant lung cancer;Molecular Carcinogenesis;2024-06-11
2. Label-free fluorescent sensor for sensitive detection of ctDNA based on water stabilized CsPbBr3 nanosheet;Biosensors and Bioelectronics;2024-06
3. A clinical decision support system to predict the efficacy for EGFR-TKIs based on artificial neural network;Journal of Cancer Research and Clinical Oncology;2023-07-11
4. Survival Analysis of 159 Patients With Advanced Non-Small-Cell Lung Cancer Resistant to First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor;Clinical Medicine Insights: Oncology;2023-01
5. The High Proportion of Discordant EGFR Mutations among Multiple Lung Tumors;Cancers;2022-06-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3